February 24, 2015
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) today announced that the first patient was successfully treated in the Company’s pivotal clinical trial in Europe assessing the efficacy of Renevia™ for the treatment of HIV-associated lipoatrophy. HIV-associated lipoatrophy is a disorder characterized by abnormal loss of body fat from under the skin that occurs in [...]
Dotmatics joins Pistoia Alliance to collaborate in the set-up of informatics standards
February 24, 2015
Bishops Stortford, UK -- Dotmatics, the leading global informatics solutions provider to the pharma, biotech, chemical and academic industries announced today that it has joined the Pistoia Alliance, a global, not-for-profit alliance of Life Sciences organisations that work together to lower barriers to innovation in R&D. The Pistoia Alliance was initially formed by major global [...]
BioNano Hits Scientific Milestone: 100 Unique Species Genetically Mapped and Analyzed
February 24, 2015
SAN DIEGO — — BioNano Genomics announced today that it has mapped and analyzed more than 100 unique species, including human, plant, animal and microbe, on the Irys® System. BioNano’s Irys System creates a high-resolution genome map for the precise assembly of DNA sequences, completion of large genomes and understanding of genomic structural variation. Achieving [...]
High Throughput PARP in vivo Pharmacodynamic Assay
February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings In recent news, AstraZeneca reported upon how their ovarian cancer [...]
Analytik Jena AG Expands its Product Range
February 23, 2015
Jena (Germany) -— Analytik Jena AG expands its product range: only half a year after the acquisition of the ICP-MS business of the Bruker Corporation in September 2014, Analytik Jena introduces two new ICP-MS products (inductively coupled plasma for use in mass spectronomy) PlasmaQuant® MS and PlasmaQuant® MS Elite.The instruments will be unveiled at the [...]
Unchained Labs UNleashes its Newest Leadership Team Members.
February 23, 2015
Pleasanton, CA – Unchained Labs, a new life science tools company, introduced the latest members of its leadership team today. Each is a veteran in the life sciences arena and come to the start-up with solid backgrounds in building booming businesses from the ground-up. Their mantra? Create big value through great products that let scientists [...]
February 23, 2015
Roche has announced the acquisition of Signature Diagnostics AG (Signature), a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies. Signature uses the samples from its [...]
Acquisition Complements 3M’s Core Filtration Technologies Platform
February 23, 2015
ST. PAUL, Minn. -- 3M announced today that it has entered into a definitive agreement with Polypore International Inc. to acquire the assets and liabilities associated with Polypore’s Separations Media business for a total purchase price of $1.0 billion. Polypore’s Separations Media business is a leading provider of microporous membranes and modules for filtration in [...]
GENOMENEXT INKS AGREEMENT WITH NATIONWIDE CHILDREN’S HOSPITAL FOR GENOMIC SEQUENCING ANALYSIS
February 23, 2015
Columbus, OH –– GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today an agreement with Nationwide Children’s Hospital under which Nationwide Children’s will integrate GenomeNext’s genomic sequencing analysis platform for both clinical laboratory services and clinical research initiatives. Despite tremendous developments in advanced sequencing technologies over the past several years, addressing [...]
February 23, 2015
ALAMEDA, Calif. -- ESI BIO, the stem cell products division of BioTime, Inc., providing stem cells and stem cell research reagents world-wide, and Pivotal Scientific Ltd, a company specializing in developing the international growth of biotech enterprises, announced an alliance agreement to develop business opportunities and manage ESI BIO’s growing network of new international distributors. [...]
